Your browser doesn't support javascript.
loading
TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer.
Le, Xiuning; Molife, Cliff; Leusch, Mark S; Rizzo, Maria Teresa; Peterson, Patrick M; Caria, Nicola; Chen, Yongmei; Gugel, Elena Gonzalez; Visseren-Grul, Carla.
Afiliação
  • Le X; MD Anderson Cancer Center, University of Texas, Houston, TX 77030, USA.
  • Molife C; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46225, USA.
  • Leusch MS; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46225, USA.
  • Rizzo MT; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46225, USA.
  • Peterson PM; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46225, USA.
  • Caria N; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46225, USA.
  • Chen Y; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46225, USA.
  • Gugel EG; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46225, USA.
  • Visseren-Grul C; Eli Lilly and Company, 3528 BJ Utrecht, The Netherlands.
Cancers (Basel) ; 14(24)2022 Dec 12.
Article em En | MEDLINE | ID: mdl-36551611
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article